A Subunit Vaccine Candidate Composed of Mpox Virus A29L, M1R, A35R, and B6R Elicits Robust Immune Response in Mice
With no specific antiviral drugs and preventive vaccines against Mpox virus (MPXV), the epidemic has led to the declaration of a Public Health Emergency of International Concern. As a developmental direction for new vaccines, studies of subunit vaccines based upon MPXV antigen proteins are lacking....
Main Authors: | Xuetao Yang, Xidan Yang, Shouwen Du, Congxia Hu, Xiu Yang, Xingyun Wang, Xing Hu, Nino Rcheulishvili, Peng George Wang, Jihui Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/9/1420 |
Similar Items
-
A cross-sectional investigation of factors influencing mpox vaccine hesitancy for students in Southwest China
by: Xiu Yang, et al.
Published: (2024-12-01) -
Identification of mpox M1R and B6R monoclonal and bispecific antibodies that efficiently neutralize authentic mpox virus
by: Zuning Ren, et al.
Published: (2024-12-01) -
Protection of Mice from Lethal Vaccinia Virus Infection by Vaccinia Virus Protein Subunits with a CpG Adjuvant
by: Sarah Reeman, et al.
Published: (2017-12-01) -
Design, evaluation, and immune simulation of potentially universal multi-epitope mpox vaccine candidate: focus on DNA vaccine
by: Nino Rcheulishvili, et al.
Published: (2023-07-01) -
Recombinant proteins A29L, M1R, A35R, and B6R vaccination protects mice from mpox virus challenge
by: Ding Tang, et al.
Published: (2023-06-01)